Welcome to our Media Center

Here in our Media Center we offer corporate press releases and other useful information for business media.

Tweets

Our CEO Adityo Prakash discusses the future of #drugdesign & how subsidiary @BlockRulesLtd is reshaping… twitter.com/i/web/status/1…
12 Feb
Really enjoyed Patrick Lyden's William M Feinberg Award talk a few days ago at #ISC19. Great overview of the develo… twitter.com/i/web/status/1…
9 Feb
Yesterday Maurizio Paciaroni highlighted recent advances in #stroke prevention at #ISC19. But, there is still room… twitter.com/i/web/status/1…
8 Feb
One of our researchers presenting new data on our new PRecision Oral Anticoagulants at #ISC19 pic.twitter.com/1N2eR97m8M
8 Feb
RT @PharmSource: .@VerseonCorp initiates patient dosing in a Phase I trial in Australia with VE-1902 for the prevention of stroke and heart…
8 Feb

Proprietary Platform

Consistently designs novel drug candidates that are unlikely to be found using conventional methods

 

Drug Programs

Multiple therapeutic areas, all with unmet (or poorly met) medical needs